U.S. Markets close in 15 mins

Yield10 Bioscience Announces Pricing of $2.9 Million Registered Direct Offering

WOBURN, Mass., March 15, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (YTEN), a Company developing new technologies to create step-change improvements in crop yield to enhance global food security, today announced that it has entered into a securities purchase agreement with certain institutional investors and existing investor Jack W. Schuler, providing for the purchase and sale of 2,421,662 shares of common stock at $1.2101 per share in a registered direct offering, resulting in total gross proceeds of approximately $2.9 million. The price per share was equal to the closing price of the common stock on the Nasdaq Capital Market on March 13, 2019. The closing of the sale of the shares is expected to take place on or about March 18, 2019, subject to the satisfaction of customary closing conditions.

Ladenburg Thalmann & Co. Inc., a subsidiary of Ladenburg Thalmann Financial Services Inc., (NYSE American:LTS) is acting as exclusive placement agent for the registered direct offering.

The shares of common stock were offered pursuant to a shelf registration statement on Form S‑3 (File No. 333-217051), which was declared effective by the United States Securities and Exchange Commission ("SEC") on April 12, 2017.

This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor will there be any sales of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. A prospectus supplement relating to the shares of common stock will be filed by Yield10 Bioscience with the SEC.  When available, copies of the prospectus supplement, together with the accompanying prospectus, can be obtained at the SEC's website at www.sec.gov or from Ladenburg Thalmann & Co. Inc., Prospectus Department, 277 Park Avenue, 26th Floor, New York, New York 10172 or by email at prospectus@ladenburg.com.

About Yield10 Bioscience

Yield10 Bioscience, Inc. is focused on developing new technologies to achieve step-change improvements in crop yield to enhance global food security. Yield10 has an extensive track record of innovation based around optimizing the flow of carbon in living systems.  Yield10 is leveraging its technology platforms and unique knowledge base to design precise alterations to gene activity and the flow of carbon in plants to produce higher yields with lower inputs of land, water or fertilizer. Yield10 is advancing several yield traits it has developed in crops such as canola, soybean, rice, wheat and corn. Yield10 is headquartered in Woburn, MA and has an Oilseeds Center of Excellence in Saskatoon, Canada. 

For more information about the company, please visit www.yield10bio.com.

(YTEN-G)

Safe Harbor for Forward-Looking Statements 

This press release contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements in this release do not constitute guarantees of future performance. Investors are cautioned that statements in this press release which are not strictly historical, including, without limitation, the completion of the financing described in this press release, constitute forward-looking statements. Such forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated, including the risks and uncertainties detailed in Yield10 Bioscience's filings with the Securities and Exchange Commission. Yield10 assumes no obligation to update any forward-looking information contained in this press release or with respect to the matters described herein.

Contacts: 
Yield10 Bioscience:
Lynne H. Brum, (617) 682-4693, LBrum@yield10bio.com

Investor Relations: 
Bret Shapiro, 561-479-8566, brets@coreir.com
Managing Director, CORE IR

Media Inquiries:
Eric Fischgrund, eric@fischtankpr.com
FischTank Marketing and PR

  • Earnings Preview: First Internet Bancorp (INBK) Q1 Earnings Expected to Decline
    Business
    Zacks

    Earnings Preview: First Internet Bancorp (INBK) Q1 Earnings Expected to Decline

    First Internet Bancorp (INBK) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2019. The earnings report, which is expected to be released on April 24, 2019, might help the stock move higher if these key numbers are better than expectations. While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

  • Here's Why StoneCo Stock Is Plunging Today
    Business
    Motley Fool

    Here's Why StoneCo Stock Is Plunging Today

    Shares of Brazilian fintech company StoneCo (NASDAQ: STNE), which gained notoriety in recent months after being added to Berkshire Hathaway's portfolio, are plummeting today. Generally speaking, moves like this are often seen after earnings announcements, but StoneCo isn't set to report earnings again for another couple months. In this case, the plunge appears to be triggered by a move from a rival company.

  • Is It Time To Consider Buying Flowserve Corporation (NYSE:FLS)?
    Business
    Simply Wall St.

    Is It Time To Consider Buying Flowserve Corporation (NYSE:FLS)?

    Flowserve Corporation (NYSE:FLS), which is in the machinery business, and is based in United States, saw a significant share price rise of over 20% in the past couple of months on the NYSE. With many analysts covering the mid-cap stock, we may expect any price-sensitive announcements have already been factored into the stock's share price. Let's examine Flowserve's valuation and outlook in more detail to determine if there's still a bargain opportunity.

  • How Do Analysts See MetLife, Inc. (NYSE:MET) Performing In The Next Couple Of Years?
    Business
    Simply Wall St.

    How Do Analysts See MetLife, Inc. (NYSE:MET) Performing In The Next Couple Of Years?

    The most recent earnings announcement MetLife, Inc.'s (NYSE:MET) released in December 2018 revealed that the business experienced a small tailwind, leading to a single-digit earnings growth of 1.8%. Below is a brief commentary on my key takeaways on how market analysts predict MetLife's earnings growth outlook over the next few years and whether the future looks even brighter than the past. I will be looking at earnings excluding extraordinary items to exclude one-off activities to get a better understanding of the underlying drivers of earnings.

  • Is Zynga Poised for Significant Growth in 2019 and Beyond?
    Business
    Market Realist

    Is Zynga Poised for Significant Growth in 2019 and Beyond?

    These Tech Stocks Could Be Overvalued at Their Current Prices(Continued from Prior Part)ZNGA's returns The stock of gaming company Zynga (ZNGA) has generated a return of 51% in the last 12 months. Since the start of 2019, the stock is up 36%.

  • Business
    Barrons.com

    GE Stock Got a Thumbs Up From a Mysterious 'Smartest Man'

    GE)'s beaten-down stock is up 25% year to date, and Melius Research analyst Scott Davis says the smartest industrial investor he knows is buying the shares. That's a tantalizing statement. Who is this investing star?

  • Is Aphria a Buy on the Dip?
    Business
    Motley Fool

    Is Aphria a Buy on the Dip?

    Shares of Aphria (NYSE: APHA) have tumbled about 16% since the company reported earnings results for its fiscal third quarter. This was the first full quarter since the company and its peers began selling adult-use recreational marijuana in Canada, and investors enthusiastic about the future are wondering if the market has overreacted and created a bargain opportunity. Let's take a closer look at the road ahead of Aphria to see if this troubled marijuana stock is a buy right now.

  • Why the Zoom and Pinterest IPOs matter so much for valuations
    Business
    Yahoo Finance Video

    Why the Zoom and Pinterest IPOs matter so much for valuations

    Zoom and Pinterest both began trading on the public market today. Yahoo Finance's Zack Guzman and Kristin Myers are joined by Lauren Smith Brody, 'The Fifth Trimester' author and founder, and Barrett Daniels, Deloitte & Touche National IPO Services Leader, to discuss why both IPOs matter so much for valuations.

  • Yamana Gold's Portfolio Is About to Look a Lot Different
    Business
    Motley Fool

    Yamana Gold's Portfolio Is About to Look a Lot Different

    Expected to close in the third quarter of 2019, the deal will net Yamana $800 million in cash payable at closing and up to an additional $125 million based on the price of gold. But it gets even better: The company will also receive a $100 million payment following the development of a pyrite circuit to optimize operations at Chapada, in addition to a 2% royalty on gold production from Suruca. Adjacent to Chapada, Suruca is a gold-only project whose oxide zone is expected to produce 50,000 ounces of gold per year during its first five years of production.

  • Why Nintendo Stock Popped Today
    News
    Motley Fool

    Why Nintendo Stock Popped Today

    What happened Shares of Nintendo (NASDAQOTH: NTDOY) were up 13.6% as of 1:30 p.m. EDT Thursday after news emerged that the company's Switch gaming console will soon begin selling in China. But Nintendo won't be selling the devices directly.

  • Why Mustang Bio Stock Is On Fire Today
    News
    Motley Fool

    Why Mustang Bio Stock Is On Fire Today

    Mustang's shares are blasting off in response to the news that an experimental gene therapy, MB-107, for "bubble boy" disease -- also known as X-linked severe combined immunodeficiency, or XSCID for short -- reportedly cured eight boys with the deadly condition. Equally critical, Mustang said that the boys are showing no signs of unintended side effects from the therapy -- an issue that has derailed prior gene therapies for XSCID. Mustang licensed MB-107 from St. Jude Children's Research Hospital.

  • Nasdaq President says watch out for these IPOs in 2019
    Business
    Yahoo Finance Video

    Nasdaq President says watch out for these IPOs in 2019

    Nasdaq President Nelson Griggs joins Yahoo Finance's Julie Hyman and Adam Shapiro to talk about the 2019 IPO rush and what we can expect for the rest of the year.

  • Pier 1 liquidation is a possibility, analysts say
    Business
    MarketWatch

    Pier 1 liquidation is a possibility, analysts say

    Pier 1 Imports Inc.'s Interim Chief Executive Cheryl Bachelder may have taken an optimistic tone after the home décor retailer reported disappointing fourth-quarter earnings, but analysts were bearish, bringing up the possibility of a liquidation in the not-so-distant future. “Given the trends in business, and its negative earnings per share, EBITDA [earnings before interest, tax, depreciation and amortization], and free cash flow, we see Pier 1 and its $1.6 billion in revenues as potentially at risk of needing liquidation if trends don't improve,” wrote KeyBanc Capital Markets analysts led by Bradley Thomas. KeyBanc thinks Kirkland's Inc. (KIRK)  , Williams-Sonoma Inc. (WSM)  , Bed Bath & Beyond Inc. (BBBY)  and At Home Group Inc. (HOME)  would benefit from a Pier 1 (PIR)  liquidation.

  • Boeing 'shielded' from 737 Max order cancellations
    Business
    MarketWatch

    Boeing 'shielded' from 737 Max order cancellations

    Don't expect Boeing Co. to face a slew of order cancellations following the 737 Max debacle. Airlines, Boeing's (BA) main customers, are hungry for fuel-efficient single-aisle aircraft such as the Max, and there's a long backlog for the jet's closest competitor, Airbus SE' (FR:AIR) A320neo, analysts at Oxford Economics said in a note Thursday. “That will shield Boeing from a mass cancellation of orders,” the analysts said.

  • 3 High-Growth Stocks That Are Just Getting Started
    Business
    Motley Fool

    3 High-Growth Stocks That Are Just Getting Started

    Choosing companies that are growing fast can be as easy as looking at several quarters of sales data, but selecting companies that are likely to to outpace their peers in their respective markets is much more difficult. That's why we reached out to a few Motley Fool contributors for their recommendations for high-growth stocks that still have a lot of potential to keep growing. They came back with Genomic Health (NASDAQ: GHDX), Shopify (NYSE: SHOP), and Okta (NASDAQ: OKTA).

  • Why Century Aluminum Stock Dropped Today
    Business
    Motley Fool

    Why Century Aluminum Stock Dropped Today

    But here's the thing: While this is "earnings season," a time of year we've been trained to expect to see big rises (and falls) in our stocks, Century Aluminum hasn't reported earnings yet. In fact, it's not expected to report earnings until April 30. Unfortunately, while Century hasn't yet reported, Alcoa (NYSE: AA) just did -- and it seems that Alcoa's bad news is turning out to be even worse news for Century.

  • Why Check Point Software Stock Dropped 8% Today
    Business
    Motley Fool

    Why Check Point Software Stock Dropped 8% Today

    Shares of IT security specialist Check Point Software Technologies (NASDAQ: CHKP) plunged more than 11% in early trading on the Nasdaq today before retracing to about an 8.2% loss as of 12:40 p.m. EDT. Check Point reported its fiscal first-quarter 2019 earnings this morning, but earnings weren't the problem this time -- guidance was. An earnings beat could have sent Check Point stock up today.

  • Should You Worry About Puma Biotechnology, Inc.'s (NASDAQ:PBYI) CEO Pay?
    Business
    Simply Wall St.

    Should You Worry About Puma Biotechnology, Inc.'s (NASDAQ:PBYI) CEO Pay?

    Alan Auerbach has been the CEO of Puma Biotechnology, Inc. (NASDAQ:PBYI) since 2011. First, this article will compare CEO compensation with compensation at similar sized companies. According to our data, Puma Biotechnology, Inc. has a market capitalization of US$1.3b, and pays its CEO total annual compensation worth US$2.8m.

  • Are Investors Undervaluing Occidental Petroleum Corporation (NYSE:OXY) By 42%?
    Business
    Simply Wall St.

    Are Investors Undervaluing Occidental Petroleum Corporation (NYSE:OXY) By 42%?

    Today we will run through one way of estimating the intrinsic value of Occidental Petroleum Corporation (NYSE:OXY) by taking the expected future cash flows and discounting them to today's value. We generally believe that a company's value is the present value of all of the cash it will generate in the future. Anyone interested in learning a bit more about intrinsic value should have a read of the Simply Wall St analysis model.

  • Harry Boxer: Two marijuana stocks are among charts worth watching
    Business
    MarketWatch

    Harry Boxer: Two marijuana stocks are among charts worth watching

    Marijuana stocks are among our top charts to watch today. Bank of America Merrill Lynch named the company as one of three marijuana stocks to buy. The stock, after sharp year-to-date gains, has been consolidating in recent weeks, but may be on the verge of its next leg up with cannabis stocks in general.

  • Here's Why Blackstone Shares Jumped on Thursday
    Business
    Motley Fool

    Here's Why Blackstone Shares Jumped on Thursday

    Shares of Blackstone Group (NYSE: BX) climbed nearly 7% on Thursday morning after the alternative asset manager reported first-quarter earnings that blew past expectations and announced plans to convert to a corporation from a partnership. Blackstone, before markets opened, said it had earned $0.71 per share in the first quarter, easily surpassing the consensus estimate for $0.53 per share in earnings. The partnership structure has prevented some classes of investors, namely pension funds and other tax-exempt institutions, from buying shares of Blackstone, and has made the company ineligible for inclusion on certain indexes.

  • Insteel Industries Inc (IIIN) Q2 2019 Earnings Call Transcript
    Business
    Motley Fool

    Insteel Industries Inc (IIIN) Q2 2019 Earnings Call Transcript

    Thank you for your interest Insteel and welcome to our second quarter 2019 earnings call, which will be conducted by Mike Gazmarian, our Vice President, CFO and Treasurer, and me. As we've discussed on recent calls, the tariffs have provided offshore competitors with a significant cost advantage relative to domestic producers by driving US prices for hot-rolled steel wire rod, our primary raw material, substantially higher than world market levels.

  • Canopy Growth's Acreage Acquisition Boosts Sentiment
    Business
    Market Realist

    Canopy Growth's Acreage Acquisition Boosts Sentiment

    Canopy Growth's Acreage Acquisition Boosts SentimentThe gains The cannabis sector appeared to show optimism after Canopy Growth (WEED)(CGC) announced that it would acquire Acreage Holdings (ACRGF), a US multi-state cannabis operator with

  • Some GameStop (NYSE:GME) Shareholders Have Taken A Painful 77% Share Price Drop
    Business
    Simply Wall St.

    Some GameStop (NYSE:GME) Shareholders Have Taken A Painful 77% Share Price Drop

    For example the GameStop Corp. (NYSE:GME) share price dropped 77% over five years. The falls have accelerated recently, with the share price down 42% in the last three months. While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance.

  • Kinder Morgan Delivers Solid First-Quarter Performance
    Business
    Motley Fool

    Kinder Morgan Delivers Solid First-Quarter Performance

    Kinder Morgan's (NYSE: KMI) first-quarter results came in about as expected. The solid start to 2019 has the company on pace to hit its full-year budget for cash flow. It also allowed Kinder Morgan to fulfill its promise to boost the dividend by 25%.